Welcome to JLABS
Empowering and enabling science to reach the people who need itLearn more
Our vision is to provide a capital efficient and flexible platform where emerging companies can transform the scientific discoveries of today into the breakthrough healthcare products of tomorrow. To accelerate scientific discovery, business, financial and operational obstacles need to be removed so that companies can do what they do best, focus on the science and bringing innovative solutions to patients.
Bringing the big company advantage to entrepreneurs
Our resident companies are the best example of why being at JLABS is a stepping stone towards success. Our capital-efficient and flexible platform provides early-stage companies with many of the advantages of being at a big company while preserving an entrepreneur’s equity and freedom to drive his or her science forward. JLABS is a “no-strings-attached” arrangement. There is no first look, no first right of refusal and no equity assigned to Johnson & Johnson or Janssen. This allows resident companies to maintain complete entrepreneurial freedom as they focus on scientific innovation.
JLABS professional operational management and programming resources free up time for entrepreneurs to build value through pipeline development. Instead of being sidetracked by getting their businesses up and running, companies residing at JLABS gain immediate access to core research facilities hosting specialized capital equipment, as well as shared administrative areas. Additionally, JLABS produces a year-round curriculum designed to assist innovators along the product development continuum.